Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Net Income	-99.56	-116.72	-32.29	-38.19	0.41	24.83	10.59	-11.64	13.54	19.15	Upgrade
Depreciation & Amortization	13.29	18.06	19.87	18.84	15.23	12.41	10.68	9.4	7.09	7.11	Upgrade
Share-Based Compensation	3.61	2.61	3.36	2.42	3.56	4.4	3.96	3.47	1.58	-0.57	Upgrade
Other Operating Activities	65.23	73.45	25.54	-0.11	-3.18	-21.87	4.61	19.54	4.41	-4.65	Upgrade
Operating Cash Flow	-17.44	-22.59	16.47	-17.04	16.02	19.78	29.84	20.76	26.62	21.05	Upgrade
Operating Cash Flow Growth	-	-	-	-	-19.01%	-33.71%	43.71%	-22.00%	26.48%	-0.87%	Upgrade
Capital Expenditures	-21.48	-28.8	-12.31	-24.25	-44.47	-33.49	-22.92	-39.57	-16.44	-14.89	Upgrade
Acquisitions	16.67	63.66	0	0	-59.87	0	-2.5	0	0	0	Upgrade
Change in Investments	0	45.1	0	0.36	7.55	0	0	-0.85	-18	1.55	Upgrade
Other Investing Activities	-	-	-	-	-	-2.1	-	-	-	-	Upgrade
Investing Cash Flow	-4.81	79.96	-12.31	-23.89	-96.8	-35.59	-25.42	-40.42	-34.44	-13.34	Upgrade
Share Issuance / Repurchase	4.82	0	0	0.03	0.33	0.06	0.71	0.32	0.12	2.3	Upgrade
Debt Issued / Paid	-2.93	-56.23	-3.01	40.2	79.4	18.92	-8.63	15.6	8.15	-9.93	Upgrade
Other Financing Activities	37.81	-0.79	-0.41	-0.21	-0.7	-5.69	-0.87	-0.5	-0.56	0.46	Upgrade
Financing Cash Flow	39.7	-57.02	-3.42	40.02	79.03	13.29	-8.8	15.42	7.71	-7.18	Upgrade
Net Cash Flow	17.45	0.35	0.74	-0.91	-1.75	-2.52	-4.39	-4.23	-0.12	0.53	Upgrade
Free Cash Flow	-38.92	-51.39	4.16	-41.29	-28.45	-13.71	6.92	-18.81	10.18	6.16	Upgrade
Free Cash Flow Growth	-	-	-	-	-	-	-	-	65.25%	-50.14%	Upgrade
Free Cash Flow Margin	-37.69%	-46.19%	4.12%	-25.80%	-5.10%	-2.62%	1.47%	-3.94%	1.89%	1.29%	Upgrade
Free Cash Flow Per Share	-1.30	-1.74	0.14	-1.42	-1.00	-0.50	0.25	-0.69	0.38	0.23	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).